Free Trial

Parkman Healthcare Partners LLC Makes New $23.78 Million Investment in Teleflex Incorporated (NYSE:TFX)

Teleflex logo with Medical background

Parkman Healthcare Partners LLC bought a new position in Teleflex Incorporated (NYSE:TFX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 96,144 shares of the medical technology company's stock, valued at approximately $23,778,000. Teleflex makes up about 3.0% of Parkman Healthcare Partners LLC's holdings, making the stock its 6th biggest holding. Parkman Healthcare Partners LLC owned approximately 0.21% of Teleflex at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Investment Management Corp of Ontario increased its stake in shares of Teleflex by 48.7% during the 3rd quarter. Investment Management Corp of Ontario now owns 1,526 shares of the medical technology company's stock worth $377,000 after purchasing an additional 500 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock worth $1,329,704,000 after purchasing an additional 147,147 shares during the last quarter. HighTower Advisors LLC increased its stake in shares of Teleflex by 1.7% during the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock worth $986,000 after purchasing an additional 66 shares during the last quarter. Centiva Capital LP increased its stake in shares of Teleflex by 15.7% during the 3rd quarter. Centiva Capital LP now owns 4,678 shares of the medical technology company's stock worth $1,157,000 after purchasing an additional 634 shares during the last quarter. Finally, Paloma Partners Management Co acquired a new position in shares of Teleflex during the 3rd quarter worth $346,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Analyst Ratings Changes

TFX has been the topic of a number of research analyst reports. Royal Bank of Canada lowered their target price on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Truist Financial reiterated a "hold" rating and issued a $227.00 target price (down from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research note on Friday, November 1st. Finally, Mizuho lowered their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $259.25.

Check Out Our Latest Research Report on TFX

Teleflex Price Performance

Shares of NYSE:TFX traded down $0.80 during midday trading on Wednesday, reaching $187.33. 525,120 shares of the company's stock were exchanged, compared to its average volume of 383,679. The company's 50 day simple moving average is $217.73 and its two-hundred day simple moving average is $222.05. The firm has a market capitalization of $8.70 billion, a PE ratio of 37.24, a price-to-earnings-growth ratio of 1.99 and a beta of 1.16. Teleflex Incorporated has a 12 month low of $185.27 and a 12 month high of $257.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts' consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period last year, the firm earned $3.64 EPS. Equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's payout ratio is 27.04%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Should you invest $1,000 in Teleflex right now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines